Association between Gastroesophageal Reflux Disease and Elastographic Parameters of Liver Steatosis and Fibrosis: Controlled Attenuation Parameter and Liver Stiffness Measurements

Table 5

Association of insufficient cardia and laboratory, demographic data, and elastographic parameters.

	OR	95% CI	value
BMI (kg/m^2)	1.04	0.999–1.086	0.057
Age (years)	1.01	0.987–1.023	0.609
AST (U/L)	1.00	0.990–1.018	0.589
ALT (U/L)	1.00	0.986–1.009	0.672
GGT (U/L)	1.00	0.992–1000	0.068
Total cholesterol (mmol/L)	1.13	0.745–1.725	0.558
HDL (mmol/L)	1.17	0.901–1.519	0.238
LDL (mmol/L)	0.84	0.532–1.340	0.473
Triglyceride (mmol/L)	0.92	0.810–1.053	0.238
Serum insulin (pmol/L)	1.00	0.987–1.006	0.466
Arterial hypertension, n (%)	1.05	0.636–1.727	0.853
Diabetes mellitus, n (%)	0.89	0.555–1.418	0.617
Hyperlipoproteinemia, n (%)	1.01	0.640–1.584	0.977
CAP (dB/m)	1.01	1.003–1.011	0.001

BMI: body mass index; AST: aspartate aminotransferase; ALT: alanine aminotransferase; GGT: gamma-glutamyl transferase; HDL: high-density lipoprotein; LDL: low-density lipoprotein; CAP: controlled attenuation parameter. .